AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 17-A-09-188.01
We recommend that the State agency bill for and collect from manufacturers rebates for pharmacy drugs and refund to the Federal Government…
The recommendation, in the publisher's words
We recommend that the State agency bill for and collect from manufacturers rebates for pharmacy drugs and refund to the Federal Government $8,045,840 (Federal share).
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- September 26, 2017
- Report
- Hawaii Did Not Bill Manufacturers for Some Rebates for Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations (A-09-16-02029) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- May 16, 2023 (publisher's date)
- Potential savings
- $8,045,840 (the publisher's figure; not realised savings)
- Publisher topics
- Managed Care, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
4 more, of which 0 are open in the publisher's file.
- We recommend that the State agency bill for and collect from manufacturers rebates for single-source and top-20 multiple-source physician-administered drugs and refund to the Federal…HHS OIG 17-A-09-188.02 · issued Sep 26, 2017 · closed May 2, 2023Closed Implemented
- We recommend that the State agency work with CMS to determine whether the non-top-20 multiple-source physician-administered drugs were eligible for rebates and, if so, upon receipt of the…HHS OIG 17-A-09-188.03 · issued Sep 26, 2017 · closed May 2, 2023Closed Implemented
- We recommend that the State agency work with CMS to determine whether the other physician-administered drugs, associated with 122,436 claim lines, were eligible for rebates and, if so,…HHS OIG 17-A-09-188.04 · issued Sep 26, 2017 · closed Nov 23, 2022Closed Implemented
- We recommend that the State agency determine which physician-administered drugs were not billed for rebates after our audit period, determine the rebates due, and upon receipt of the…HHS OIG 17-A-09-188.05 · issued Sep 26, 2017 · closed Jul 22, 2022Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.